Drug · DIN 02454319
JAMP RISPERIDONE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 10, 2026; first marketed August 22, 2018.
- Drug Identification Number (DIN)
- 02454319
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- July 29, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE (RISPERIDONE TARTRATE) | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 10, 2026: NOC 37873Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Change in product name. Change in product name.Update to Product Monograph (to align with CRP approved PM). Update to package labels. Update to Instructions for Use
- April 27, 2016: NOC 18035Abbreviated New Drug Submission (ANDS)